By Counterforce Health Team in Kanuma (sebelipase alfa) —

Renewing Kanuma (Sebelipase Alfa) Coverage with Humana in Michigan: Annual Review Timeline & Documentation Guide

Answer Box: Renewing Your Kanuma Coverage

Kanuma (sebelipase alfa) requires annual prior authorization renewal with Humana Medicare plans in Michigan. Start the renewal process 60-90 days before your current approval expires to avoid treatment gaps. Your prescriber must submit updated clinical documentation including recent ALT/AST levels, lipid panels, and response to therapy. If denied, you have 65 days to appeal internally, then 127 days to file for Michigan DIFS external review. Contact Humana at 1-800-833-6917 to check your current approval status and renewal timeline.

Table of Contents

  1. When to Start Your Renewal Process
  2. Required Lab Work and Clinical Updates
  3. What to Include in Your Renewal Packet
  4. Timeline and Submission Process
  5. If Your Coverage Lapses
  6. Annual Plan Changes to Monitor
  7. Michigan Appeals Process
  8. Personal Renewal Tracker
  9. FAQ

Renewal Triggers: When to Start Early

Your Kanuma prior authorization doesn't automatically renew with your Humana plan. Most specialty drug approvals expire after 12 months, requiring fresh documentation of medical necessity and treatment response.

Key Warning Signs to Act Now

  • 90 days before expiration: Ideal time to begin gathering updated labs and clinical notes
  • 60 days before: Latest recommended start date to avoid potential gaps
  • Formulary changes: If you receive an Annual Notice of Change (ANOC) mentioning specialty drug updates
  • Plan switches: Moving between Humana plans or from another insurer requires new PA
Note: Humana Medicare Advantage plans automatically renew January 1st, but your drug approvals follow separate timelines. Check your current status in your MyHumana account.

Monthly Monitoring Schedule

Month Action Item Who Does It
Month 9 Check approval expiration date Patient/caregiver
Month 10 Schedule lab work (ALT, AST, lipids) Prescriber
Month 11 Compile renewal documentation Prescriber + patient
Month 12 Submit renewal PA Prescriber

Evidence Update: Proving Ongoing Medical Necessity

Humana requires fresh evidence that Kanuma remains medically necessary and effective. This isn't just a rubber stamp renewal—you need to demonstrate continued benefit.

Required Lab Monitoring Parameters

Primary effectiveness markers (drawn within 30-60 days of renewal):

  • ALT/AST levels: Target ≥30% reduction from baseline or normalization
  • Lipid panel: LDL-C, HDL-C, total cholesterol, triglycerides
  • LAL enzyme activity: If initial levels were borderline, repeat testing may be requested

Secondary monitoring (as clinically indicated):

  • Liver imaging (ultrasound or MRI) showing hepatomegaly improvement
  • Growth parameters in pediatric patients
  • Functional assessments and quality of life measures
Clinician Corner: Document specific improvements like "ALT decreased from 150 U/L at baseline to 45 U/L at 12 months" rather than generic statements. LAL-D monitoring guidelines emphasize quantifiable response criteria.

Documenting Treatment Response

Your renewal packet should demonstrate:

  • Clinical improvement: Reduced hepatomegaly, normalized liver enzymes, improved lipid profile
  • Functional benefits: Better energy, reduced fatigue, improved quality of life
  • Adherence: Consistent infusion attendance and no missed doses
  • Tolerability: Management of any infusion reactions or side effects

Addressing Adverse Events

If you've experienced infusion reactions or other side effects, document:

  • How reactions were managed (premedication, rate adjustments)
  • Whether benefits still outweigh risks
  • Any protocol modifications that improved tolerability

Renewal Packet: Must-Include Documentation

Core Requirements Checklist

Clinical Documentation:

  • Updated letter of medical necessity from prescriber
  • Recent lab results (ALT, AST, lipid panel within 60 days)
  • Treatment response summary with specific metrics
  • Current dosing regimen and infusion schedule
  • Documentation of LAL-D diagnosis (enzyme levels, genetic testing)

Administrative Items:

  • Completed PA form (varies by Humana plan)
  • Current insurance card and member ID
  • Prescriber's NPI and contact information
  • Preferred infusion site details

Medical Necessity Letter Structure

Your prescriber's renewal letter should include:

  1. Patient identification: Name, DOB, member ID, diagnosis codes
  2. LAL-D confirmation: Original enzyme levels, genetic testing results
  3. Treatment history: Start date, current dose, infusion frequency
  4. Response documentation: Specific lab improvements with dates and values
  5. Ongoing necessity: Why continued treatment is essential
  6. Alternative assessment: Confirmation no other treatments are appropriate
Template Language: "Patient continues to demonstrate significant clinical benefit from Kanuma therapy, with ALT levels remaining stable at 42 U/L (down from baseline 165 U/L) and maintained improvement in hepatomegaly as evidenced by recent imaging."

Timeline: When to Submit and What to Expect

Optimal Submission Schedule

90 days before expiration:

  • Schedule lab work and provider appointment
  • Request updated clinical notes from infusion center

60 days before expiration:

  • Prescriber submits renewal PA to Humana
  • Patient confirms submission via MyHumana portal

30 days before expiration:

  • Follow up if no decision received
  • Prepare appeal documentation if needed

Humana Decision Timelines

Review Type Timeline Expedited Option
Standard PA renewal 15 days 72 hours if urgent
Complex cases Up to 30 days 72 hours with physician letter
Appeal (internal) 65 days to file 72 hours for expedited

Submission Methods:

  • Provider portal (fastest): Real-time status updates
  • Fax: (verify current number with Humana)
  • Phone: 1-800-833-6917 for provider services

If Your Coverage Lapses: Bridge Options

Immediate Steps if Approval Expires

  1. Contact Humana immediately: Request retroactive coverage consideration
  2. File expedited appeal: If renewal was denied, emphasize medical urgency
  3. Explore temporary coverage: Some plans offer 30-day emergency supplies

Bridge Therapy Considerations

While waiting for approval decisions:

  • Manufacturer support: Alexion Access Navigator may provide temporary assistance
  • Clinical monitoring: Continue scheduled infusions if possible to maintain therapeutic levels
  • Documentation: Keep detailed records of any treatment gaps for appeal purposes
Important: Never stop Kanuma abruptly without medical supervision. LAL-D symptoms can return quickly, and restarting therapy may require dose escalation.

Financial Assistance During Appeals

  • Patient assistance programs: Income-based support may be available
  • State programs: Michigan residents may qualify for additional coverage support
  • Hospital charity care: If receiving infusions at hospital-based centers

Annual Changes: What to Re-Verify Each Year

Formulary Status Updates

Check annually:

  • Kanuma's tier placement (typically Tier 5 specialty)
  • Prior authorization requirements (may become more or less restrictive)
  • Preferred infusion sites or network changes
  • Cost-sharing modifications

Plan Design Shifts

Humana may adjust:

  • Step therapy requirements: New drugs might be added as "try first" options
  • Quantity limits: Dosing restrictions based on weight or age
  • Site of care: Home infusion vs. clinic requirements
  • Provider network: Changes to approved infusion centers
2025 Update: Medicare Part D plans face new out-of-pocket maximums. Review current changes that may affect your specialty drug costs.

Documentation of Plan Changes

Keep records of:

  • Annual Notice of Change (ANOC) documents
  • Updated Evidence of Coverage (EOC)
  • New formulary listings
  • Provider network directories

Michigan Appeals Process: Your Rights and Deadlines

Internal Appeals with Humana

Timeline: 65 days from denial date to file Process:

  1. Call member services: 1-800-833-6917
  2. Submit written appeal with additional documentation
  3. Request expedited review if medically urgent (72-hour decision)

Michigan DIFS External Review

If Humana upholds the denial, Michigan's Department of Insurance and Financial Services provides independent review.

Key Details:

  • Filing deadline: 127 days from final internal denial
  • Cost: Free to patients
  • Timeline: 60 days standard, 72 hours expedited
  • Decision: Binding on Humana

How to File:

  1. Complete DIFS Online External Review Form
  2. Include physician letter for expedited review
  3. Attach all denial letters and supporting documentation
Michigan Advantage: DIFS has successfully overturned denials for rare disease medications, including expensive enzyme replacement therapies, when medical necessity is clearly documented.

Expedited Appeals Criteria

Request 72-hour review if:

  • Delay would seriously jeopardize your health
  • You're currently receiving therapy that would be interrupted
  • Disease progression would occur without continued treatment

Required: Physician letter stating why delay would harm your health.

Personal Renewal Tracker

Annual Checklist Template

Patient Information:

  • Name: _______________
  • Humana Member ID: _______________
  • Current PA expiration date: _______________
  • Prescriber: _______________
  • Infusion site: _______________

Renewal Progress:

  • Labs scheduled (date: ______)
  • Provider appointment (date: ______)
  • PA submitted (date: ______)
  • Decision received (date: ______)
  • Appeal filed if needed (date: ______)

Key Contacts:

  • Humana member services: 1-800-833-6917
  • Provider PA department: _______________
  • Michigan DIFS: 877-999-6442
  • Alexion Access Navigator: _______________

Counterforce Health Support

Navigating specialty drug renewals can be overwhelming, especially for complex conditions like LAL-D. Counterforce Health helps patients and clinicians turn insurance denials into targeted, evidence-backed appeals by analyzing denial letters, plan policies, and clinical notes to draft point-by-point rebuttals aligned with each payer's specific requirements.

FAQ

Q: How long before expiration should I start the renewal process? A: Begin 60-90 days early. This allows time for lab work, documentation gathering, and potential appeals if needed.

Q: What if my labs show the medication isn't working as well? A: Document any clinical benefits beyond lab values, such as symptom improvement or stabilization. Your prescriber may need to adjust the narrative to emphasize preventing disease progression.

Q: Can I switch Humana plans and keep my Kanuma coverage? A: You'll need a new prior authorization with any plan change. Start the PA process immediately after enrollment to avoid gaps.

Q: What if Humana removes Kanuma from their formulary? A: You can request a formulary exception. This requires demonstrating that covered alternatives are ineffective or inappropriate for LAL-D.

Q: How do I get expedited review in Michigan? A: Your physician must certify that delay would jeopardize your health. Include this letter with both Humana expedited appeals and DIFS external review requests.

Q: Are there financial assistance programs for Kanuma? A: Yes, manufacturer programs and patient foundations may help. However, Medicare patients have limited copay assistance options due to federal anti-kickback rules.

Q: What happens if I miss infusions during an appeal? A: LAL-D symptoms may return. Work with your care team to maintain treatment if possible, and document any clinical decline to strengthen your appeal.

Q: Can I appeal to Michigan DIFS for Medicare coverage denials? A: Yes, Michigan's external review process applies to all health insurance, including Medicare Advantage plans like Humana.

Sources & Further Reading

Disclaimer: This information is for educational purposes and should not replace medical advice. Coverage decisions depend on individual circumstances and plan details. Always verify current requirements with Humana and consult your healthcare provider. For assistance with insurance appeals in Michigan, contact DIFS at 877-999-6442.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.